| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1146/ANNUREV.ME.40.020189.000335 |
| P698 | PubMed publication ID | 2658755 |
| P2093 | author name string | Kelton JG | |
| Warkentin TE | |||
| P921 | main subject | thrombocytopenia | Q585285 |
| P304 | page(s) | 31-44 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | Annual Review of Medicine | Q567363 |
| P1476 | title | Heparin-induced thrombocytopenia | |
| P478 | volume | 40 |
| Q35657450 | Ancrod for coronary angioplasty |
| Q30469754 | Ancrod: the use of snake venom in the treatment of patients with heparin-induced thrombocytopenia and thrombosis undergoing coronary artery bypass grafting: nursing management |
| Q41046059 | Antiplatelet and anticoagulant use after myocardial infarction |
| Q90411270 | Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins |
| Q33428198 | Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test |
| Q36652525 | Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders. |
| Q33337297 | Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia |
| Q26828351 | HITlights: a career perspective on heparin-induced thrombocytopenia |
| Q33496570 | Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts |
| Q33361848 | Heparin induced thrombocytopenia. A frequently unrecognised complication after major orthopedic surgery |
| Q28378423 | Heparin induced thrombosis: an important complication of heparin prophylaxis for thromboembolic disease in surgery |
| Q33333315 | Heparin-Induced thrombocytopenia: minimising the risks in the elderly patient |
| Q28343053 | Heparin-associated thrombocytopenia: Successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins |
| Q33374936 | Heparin-induced thrombocytopaenia complicated by bilateral adrenal haemorrhage |
| Q93912866 | Heparin-induced thrombocytopenia and thrombosis |
| Q28320738 | Heparin-induced thrombocytopenia in a child |
| Q33489520 | Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance. |
| Q33368659 | Immunocytochemical localization of platelets in baboon hepatic sinusoids using monoclonal mouse anti-human platelet glycoprotein IIIa following induction of thrombocytopenia |
| Q30305538 | Management of Acute Ischemic Coronary Syndromes: The Present and Future |
| Q33490306 | Myeloproliferative and metabolic causes |
| Q40725160 | Novel antithrombotic therapy. |
| Q40559317 | Pharmacology of current and future antithrombotic therapies. |
| Q28316082 | Risk-benefit assessment of anticoagulant therapy |
| Q52609630 | The Role of Single-Molecule Force Spectroscopy in Unraveling Typical and Autoimmune Heparin-induced Thrombocytopenia. |
| Q33404176 | Why is the platelet count low: should I be concerned about heparin-induced thrombocytopenia? |
Search more.